Recent Updates in the Treatment of CML

The University of Alabama at Birmingham School of Medicine
O

Treating CML Patients With TKI Resistance vs. TKI Intolerance

By The University of Alabama at Birmingham School of Medicine FEATURING Omer Jamy
By The University of Alabama at Birmingham School of Medicine FEATURING Omer Jamy
297 views
November 13, 2023
Comments 0
Login to view comments. Click here to Login
06:26

Managing TKI AEs in CML: Thrombocytopenia, Hypertension, Pancreatic …

Akriti Jain

89 views
07:55

ASH 2023 Insights: "Treatment Patterns & Clinical Outcomes Among Pat…

Insights from 2023 ASH Annual Meeting

E. Atallah

635 views
18:55

iCMLf Conversations: CML Clinical Highlights of EHA 2023

International CML Foundation

A. Hochhaus

155 views
17:30

SOHO 2023: Rational TKI Choice in CML

SOHO 2023 Eleventh Annual Meeting

M. Deininger

309 views
16:25

SOHO 2023: The New ELN Laboratory Recommendations for the Diagnosis …

SOHO 2023 Eleventh Annual Meeting

N. Cross

430 views
06:15

Unmet Needs in CML: Patient & Physician Perspectives From the CML SU…

Jorge Cortés

82 views
04:16

Efficacy and Safety of Asciminib in Ph+ CML

Luke Fletcher

948 views
11:02

ASH 2023 Insights: "Asciminib Combined With Dasatinib and Prednisone…

Dana-Farber Cancer Institute

M. Luskin

207 views
08:32

ASH 2023 Insights: "ALLG CML13 ASCEND-CML Study - Asciminib Treatmen…

Insights from 2023 ASH Annual Meeting

D. Yeung

125 views